Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![amit_gupta444 Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1198165564750852096.png) Amit Gupta [@amit_gupta444](/creator/twitter/amit_gupta444) on x 1138 followers
Created: 2025-06-04 03:08:23 UTC

Zydus Lifesciences: The company is acquiring two US-based biologics manufacturing facilities from Agenus for $XX million upfront and has also secured exclusive licensing rights for Agenus's next-generation immuno-oncology platforms, Botensilimab and Balstilimab.


XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1930099284994576500/c:line.svg)

**Related Topics**
[$zyduslifebo](/topic/$zyduslifebo)
[amit](/topic/amit)

[Post Link](https://x.com/amit_gupta444/status/1930099284994576500)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

amit_gupta444 Avatar Amit Gupta @amit_gupta444 on x 1138 followers Created: 2025-06-04 03:08:23 UTC

Zydus Lifesciences: The company is acquiring two US-based biologics manufacturing facilities from Agenus for $XX million upfront and has also secured exclusive licensing rights for Agenus's next-generation immuno-oncology platforms, Botensilimab and Balstilimab.

XX engagements

Engagements Line Chart

Related Topics $zyduslifebo amit

Post Link

post/tweet::1930099284994576500
/post/tweet::1930099284994576500